The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain.
Open accessAbstract
We characterized the binding of [125I]epidepride to dopamine D2-like and D3-like receptors in tissue sections of human striatum. The competition for binding of [125I]epidepride by domperidone, quinpirole, and 7-hydroxy-N,N-di(1-propyl)-2-aminotetralin (7-OH-DPAT) was best fit by assuming one site in the caudate but two sites in nucleus accumbens. Guanosine 5'-[beta, gamma-imido]triphosphate showed a large modulatory influence in agonist inhibition of [125I]epidepride binding in caudate but not in nucleus accumbens. The binding of [125I]epidepride in the presence of 7-OH-DPAT (1000-fold selective for D3-like versus D2-like sites) and domperidone (20-fold selective for D2-like versus D3-like sites) was used to quantify the numbers of D2-like and D3-like receptors in areas of human brain. The distribution of D2-like and D3-like receptors was largely nonoverlapping. Binding of [125I]epidepride to D3-like receptors was negligible in the dorsal striatum but was concentrated in islands of dense binding in the nucleus accumbens and ventral putamen that aligned with acetylcholinesterase-poor striosomes. Binding to D3-like receptors was also enriched in the internal globus pallidus, ventral pallidum, septum, islands of Calleja, nucleus basalis, amygdalostriatal transition nucleus of the amygdala, central nucleus of the amygdala, and ventral tegmental area. Binding of [125I]epidepride to D2 but not D3 receptors was detected in cortex and hippocampus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R. (1990) · Science · doi:10.1126/science.2147780 · Cited by 2,967
Van Tol, H. H. M., Bunzow, J. R., Guan, H.-C., Sunahara, R. K., Seeman, P., Niznik, H. B., & Civelli, O. (1991) · Nature · doi:10.1038/350610a0 · Cited by 2,014
Lévesque, D., Diaz, J., Pilon, C., Martres, M. P., Giros, B., Souil, E., Schott, D., Morgat, J. L., Schwartz, J. C., & Sokoloff, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.8155 · Cited by 674
Mansour, A., Meador-Woodruff, J., Bunzow, Jr., Civelli, O., Akil, H., & Watson, S. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-08-02587.1990 · Cited by 467
Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain
McGeer, P. L., McGeer, E. G., Suzuki, J., Dolman, C. E., & Nagai, T. (1984) · Neurology · doi:10.1212/wnl.34.6.741 · Cited by 457
Sokoloff, P., Andrieux, M., Besançon, R., Pilon, C., Martres, M.-P., Giros, B., & Schwartz, J.-C. (1992) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(92)90107-7 · Cited by 400
Jimenez-Castellanos, J., & Graybiel, A. M. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90285-5 · Cited by 271
Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors.
Chio, C. L., Lajiness, M. E., & Huff, R. M. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09903-1 · Cited by 254
Molecular biology of the dopamine receptors
Civelli, O., Bunzow, J. R., Grandy, D. K., Zhou, Q.-Y., & Van Tol, H. H. M. (1991) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(91)90001-x · Cited by 239
Expression and pharmacological characterization of the human D3 dopamine receptor.
Freedman, S. B., Patel, S., Marwood, R., Emms, F., Seabrook, G. R., Knowles, M. R., & McAllister, G. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38490-9 · Cited by 223
Cited by
Alcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior
Spanagel, R. (2009) · Physiological Reviews · doi:10.1152/physrev.00013.2008 · Cited by 634
Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy
Tziortzi, A. C., Searle, G. E., Tzimopoulou, S., Salinas, C., Beaver, J. D., Jenkinson, M., Laruelle, M., Rabiner, E. A., & Gunn, R. N. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.06.044 · Cited by 452
Gurevich, E. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00066-9 · Cited by 431
Self-citationThe involvement of dopamine in the modulation of sleep and waking
Monti, J. M., & Monti, D. (2007) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2006.08.003 · Cited by 415
The D3 Dopamine Receptor: Neurobiology and Potential Clinical Relevance
Levant, B. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01327-9 · Cited by 385
Kaar, S. J., Natesan, S., McCutcheon, R., & Howes, O. D. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107704 · Cited by 383
Piggott, M. A., Marshall, E. F., Thomas, N., Lloyd, S., Court, J. A., Jaros, E., Burn, D., Johnson, M., Perry, R. H., McKeith, I. G., et al. (1999) · Brain · doi:10.1093/brain/122.8.1449 · Cited by 330
The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence
Heidbreder, C. A., Gardner, E. L., Xi, Z.-X., Thanos, P. K., Mugnaini, M., Hagan, J. J., & Ashby, C. R. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.033 · Cited by 322
Xu, M., Koeltzow, T. E., Santiago, G. T., Moratalla, R., Cooper, D. C., Hu, X.-T., White, N. M., Graybiel, A. M., White, F. J., & Tonegawa, S. (1997) · Neuron · doi:10.1016/s0896-6273(00)80965-4 · Cited by 315
Adaptive Increase in D3Dopamine Receptors in the Brain Reward Circuits of Human Cocaine Fatalities
Staley, J. K., & Mash, D. C. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-19-06100.1996 · Cited by 308
The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking
MONTI, J., & JANTOS, H. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00929-1 · Cited by 302
de la Mora, M. P., Gallegos-Cari, A., Arizmendi-García, Y., Marcellino, D., & Fuxe, K. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.10.010 · Cited by 296
“, 1993) autoradiography (Palacios et al., 1988; Camps et al., 1989; Cortés et al., 1989; De Keyser et al., 1989; Herroelen et al., 1994; Murray et al., 1994; Gurevich and Joyce, 1999) and imaging studies (Okubo et al.”
BackgroundReversal learning in Parkinson's disease depends on medication status and outcome valence
Cools, R., Altamirano, L., & D’Esposito, M. (2006) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2006.03.030 · Cited by 289
Klos, K. J., Bower, J. H., Josephs, K. A., Matsumoto, J. Y., & Ahlskog, J. E. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.06.005 · Cited by 283
Reavill, C., Taylor, S. G., Wood, M. D., Ashmeade, T., Austin, N. E., Avenell, K. Y., Boyfield, I., Branch, C. L., Cilia, J., Coldwell, M. C., et al. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39184-0 · Cited by 287
Wolf, S. S., Jones, D. W., Knable, M. B., Gorey, J. G., Lee, K. S., Hyde, T. M., Coppola, R., & Weinberger, D. R. (1996) · Science · doi:10.1126/science.273.5279.1225 · Cited by 252
Boileau, I., Payer, D., Chugani, B., Lobo, D., Behzadi, A., Rusjan, P. M., Houle, S., Wilson, A. A., Warsh, J., Kish, S. J., et al. (2013) · Addiction · doi:10.1111/add.12066 · Cited by 190
Court, J. A., Lloyd, S., Thomas, N., Piggott, M. A., Marshall, E. F., Morris, C. M., Lamb, H., Perry, R. H., Johnson, M., & Perry, E. K. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00088-8 · Cited by 135
Ersche, K. D., Roiser, J. P., Abbott, S., Craig, K. J., Müller, U., Suckling, J., Ooi, C., Shabbir, S. S., Clark, L., Sahakian, B. J., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.06.033 · Cited by 128
The human basal forebrain. Part II
Heimer, L., de Olmos, J. S., Alheid, G. F., Pearson, J., Sakamoto, N., Shinoda, K., Marksteiner, J., & Switzer, R. C. (1999) · Handbook of Chemical Neuroanatomy · doi:10.1016/s0924-8196(99)80024-4 · Cited by 125
Drd3 Signaling in the Lateral Septum Mediates Early Life Stress-Induced Social Dysfunction
Shin, S., Pribiag, H., Lilascharoen, V., Knowland, D., Wang, X.-Y., & Lim, B. K. (2018) · Neuron · doi:10.1016/j.neuron.2017.11.040 · Cited by 120
Willeit, M., Ginovart, N., Graff, A., Rusjan, P., Vitcu, I., Houle, S., Seeman, P., Wilson, A. A., & Kapur, S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301400 · Cited by 107
“…high BPs in GP and ventral portions of the neo-striatum, regions where postmortem studies have shown relatively high densities of D3 receptors (Seeman et al, 2006; Gurevich and Joyce, 1999; Murray et al, 1994), is compatible with a significant contribution of D3 receptors to the captured signal.”
BackgroundCropley, V. L., Innis, R. B., Nathan, P. J., Brown, A. K., Sangare, J. L., Lerner, A., Ryu, Y. H., Sprague, K. E., Pike, V. W., & Fujita, M. (2008) · Synapse · doi:10.1002/syn.20506 · Cited by 104
Mizrahi, R., Kenk, M., Suridjan, I., Boileau, I., George, T. P., McKenzie, K., Wilson, A. A., Houle, S., & Rusjan, P. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.347 · Cited by 101
The dopamine D3/D2 receptor agonist 7-OH-DPAT induces cognitive impairment in the marmoset
Smith, A. G., Neill, J. C., & Costall, B. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00230-5 · Cited by 71
Joyce, J. N. (2001) · Synapse · doi:10.1002/syn.1035 · Cited by 47
“In the human brain, the highest expression of D3 receptor is in ventral striatum, but is also enriched in the output structures of the limbic striato-pallidalthalamo pathway (Gurevich and Joyce, 1999; Murray et al., 1994; Meador-Woodruff et al., 1996; Morissette et al., 1998).”
BackgroundSelf-citationOrzeł-Gryglewska, J., Matulewicz, P., & Jurkowlaniec, E. (2015) · Synapse · doi:10.1002/syn.21843 · Cited by 31
Striatal topographical organization: Bridging the gap between molecules, connectivity and behavior
Basile, G. A., Bertino, S., Bramanti, A., Ciurleo, R., Anastasi, G. P., Milardi, D., & Cacciola, A. (2021) · European Journal of Histochemistry · doi:10.4081/ejh.2021.3284 · Cited by 29
Metadata
- Authors
- Murray, A. M., Ryoo, H. L., Gurevich, E., & Joyce, J. N.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1994-11-08
- Volume
- 91
- Issue
- 23
- Pages
- 11271-11275
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1967823110
- Cited by
- 325
- References
- 20
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.